Exemestane reduces breast cancer in high-risk women, researchers show
Saturday, June 4, 2011 - 18:30
in Health & Medicine
A major announcement that the drug exemestane significantly reduces the risk of breast cancer in high-risk, postmenopausal women is the result of an international, randomized double-blind phase III clinical trial.